Items where authors include "Davis, P"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Kanthimathinathan, HK, Buckley, H, Lamming, C et al. (5 more authors) (2021) Characteristics of Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Comparison With Influenza in Children Admitted to U.K. PICUs. Critical Care Explorations, 3 (3). e0362. ISSN 2639-8028

Richards-Belle, A, Davis, P, Drikite, L et al. (11 more authors) (2020) FIRST-line support for assistance in breathing in children (FIRST-ABC): a master protocol of two randomised trials to evaluate the non-inferiority of high-flow nasal cannula (HFNC) versus continuous positive airway pressure (CPAP) for non-invasive respiratory support in paediatric critical care. BMJ Open, 10 (8). e038002. ISSN 2044-6055

Young, J P W orcid.org/0000-0001-5259-4830, Crossman, L C, Johnston, A W B et al. (29 more authors) (2006) The genome of Rhizobium leguminosarum has recognizable core and accessory components. Genome biology. R34. -. ISSN 1474-760X